about
Protein bio-corona: critical issue in immune nanotoxicology.Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition.Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics.Synthesis and antiproliferative activity of two diastereomeric lignan amides serving as dimeric caffeic acid-l-DOPA hybrids.The role of heparins and nano-heparins as therapeutic tool in breast cancer.Biochemical and toxicological evaluation of nano-heparins in cell functional properties, proteasome activation and expression of key matrix molecules.Shed proteoglycans in tumor stroma.Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules.Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.Insights into the key roles of epigenetics in matrix macromolecules-associated wound healing.Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer.Collagen Fiber Array of Peritumoral Stroma Influences Epithelial-to-Mesenchymal Transition and Invasive Potential of Mammary Cancer CellsAdvances in targeting epidermal growth factor receptor signaling pathway in mammary cancerHyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancerProteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and TherapeuticsDynamic Interplay between miRNAs and the Extracellular Matrix Influences the Tumor MicroenvironmentEstrogen receptor-mediated targeting of the extracellular matrix network in cancer
P50
Q37651354-97B29262-3D3F-43AF-9CC0-81BCCA534164Q37717157-EDF7C559-145E-4A27-A9B2-FC319E23042CQ38630004-8BE672C1-1FEA-4ECC-8782-181BA8EFD2D7Q38770727-14F51374-C301-4D6F-8EBF-31C946F783E3Q38772514-9812B46D-5337-49F1-8B41-C01A93A4EFF3Q38806104-7EFED614-617E-4DA3-96C4-E361D3CAEBCAQ38827121-57E255D0-AAD7-48FB-B6BA-57E4A5067F1DQ38882752-FE5462E3-D7F9-4709-A5C5-9B828ECACB27Q39766044-2832E9A5-79B6-480C-82C5-48B67EA249AEQ41328909-E9044AF7-3B10-412B-9FC8-94959058BC97Q46121051-7A173670-16B7-434A-8018-A485947641AFQ50100289-EB56FDC3-5E05-447E-A8D9-D97BE384AA41Q50109651-79B2E682-7B5A-490E-BAD7-A16CC7D4022AQ64243069-D82AAB0E-3A33-45CD-9CFC-A8EF2BA78064Q90713967-4332A42E-854E-4E42-AD40-837D6A6D9620Q91366828-8C1776C3-28BB-45A7-8856-9DE9627D083DQ91382906-927B14A3-4242-4E7B-8AF8-0D233F169817Q91751591-B3BAB10A-DA84-4C98-A5AD-656728252328Q91924938-CC062F34-31EF-4AFE-B2BF-63EA24BEB9F7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Zoi Piperigkou
@en
Zoi Piperigkou
@nl
type
label
Zoi Piperigkou
@en
Zoi Piperigkou
@nl
prefLabel
Zoi Piperigkou
@en
Zoi Piperigkou
@nl
P31
P496
0000-0002-0472-5389